Filing Details

Accession Number:
0001209191-15-050046
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-04 14:30:37
Reporting Period:
2015-06-03
Filing Date:
2015-06-04
Accepted Time:
2015-06-04 14:30:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326732 Xencor Inc XNCR Pharmaceutical Preparations (2834) 201622502
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1218981 Iii S John Stafford 350 N. Orleans, 2N
Chicago IL 60654
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-03 10,000 $18.76 100,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,487,240 Indirect By Limited Liability Company
Footnotes
  1. Reported transaction occured pursuant to a Rule 10b5-1 Plan adopted March 11, 2015.
  2. The weighted average sale price for the transaction reported was $18.7584, and the range of prices were between $18.11 and $19.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. These securities are held of record by Ronin Trading, LLC, a limited liability company owned and managed by the Reporting Person. The Reporting Person is the indirect beneficial owner of all the shares of common stock of Xencor, Inc. held of record by Ronin Trading, LLC.